Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Radical -xh acid – or anhydride – acid halide or salt thereof...
Patent
1991-03-14
1994-04-26
Fay, Zohreh
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Radical -xh acid, or anhydride, acid halide or salt thereof...
514571, 514913, A61K 31195, A61K 3119
Patent
active
053067312
ABSTRACT:
This invention is directed to improved treatment for glaucoma. It involves delivering to the eye molecules which increase the outflow of aqueous humor, in conjunction with masking agents. The masking agents reduce the side effects of the therapeutically active molecules by masking the sulfhydryl reactive groups on the molecules. The masking agents can be delivered separately from the molecules, or as adducts of the molecules.
REFERENCES:
patent: 4590210 (1986-05-01), Landham
patent: 4596771 (1986-06-01), Cidlowski et al.
patent: 4777130 (1988-10-01), Maes
patent: 4826879 (1989-05-01), Yamamoto et al.
patent: 4829011 (1989-05-01), Gibbons
patent: 4847209 (1989-07-01), Lewis et al.
patent: 4891324 (1990-01-01), Pease et al.
patent: 4965192 (1990-10-01), Maes
Epstein et al., "Influences of glutathione and sulfhydryl containing compounds on aqueous humor outflow function," Chem. Abst. vol. 113:523 (Aug. 27, 1990).
Epstein et al., "N-ethylmaleimide increases the facility of aqueous outflow of excised monkey & calf eyes", Invest. Ophthalmol. Vis. Sci. 22:752-756 (1982).
Magro et al., "Effect of sulfhydryl-reactive ATPase inhibitors upon mast cell and basophil activation", Int. Archives of Allergy and Applied Immunology 77:41-45 (1983).
Epstein et al., "The effect of diamide on lens glutathione and lens membrane function", Invest. Ophthalmol. Vis. Sci. 9:629-638 (1970).
Lindenmayer et al., "Morphology and Function of the Aqueous Outflow System in Monkey Eyes Perfused with Sulfhydryl Reagents", Invest. Opthalmol. Vis. Sci. 24:710-717 (1983).
Epstein et al., "Effect of iodacetamide perfusion on outflow facility and metabolism of the trabecular meshwork", Invest. Ophthalmol. Vis. Sci. 20:625-631 (May 1981).
Anderson et al., "Metabolism of calf trabecular (reticular) meshwork", Invest. Ophthalmol. Vis. Sci. 19:13-20 (Jan. 1980).
Kahn et al., "Glutathione in Calf Trabecular Meshwork and its Relation to Aqueous Humor Outflow Facility", Invest. Ophthalmol. Vis. Sci. 24:1283-1287 (1983).
Scott et al., "Glutathione Peroxidase of Calf Trabecular Meshwork", Invest. Ophthalmol. Vis. Sci. 25:599-602 (1984).
Freddo et al., "Influence of Mercurial Sulfhydryl Agents on Aqueous Outflow Pathways in Enucleated Eyes", Invest. Ophthalmol. Vis. Sci. 25:278-285 (1984).
Epstein et al., "The Biochemistry of Outflow Mechanisms", Applied Pharmacology in the Medical Treatment of Glaucomas pp. 135-150 (Aug. 1984).
Epstein, D. L., "Open Angle Glaucoma", Arch. Ophthalmol. 105:1187-1188 (Sep. 1987).
Epstein et al., "Influence of Etharcynic Acid on Outflow Facility in the Monkey and Calf Eye", Invest. Ophthalmol. Vis. Sci. 28:2067-2075 (1987).
Epstein et al., "Paracellular Outflow Routes Through the Inner Wall of Schlemm's Canal in Cynomolgus Monkeys", Arvo Abstract (1988).
Ozment et al., "The Effect of Intracameral Ethacrynic Acid on Intraocular Pressure of Living Monkeys", Arvo Abstract (1988).
Peczon et al., "Diuretic Drugs in Glaucoma", American Journal of Opthalmology 66:680-683 (Oct. 1968).
Guenther et al., "Superficity of ethacrynic acid as a sulfydryl reagent", Pharmacodynamics 84:99192h p. 23 (1976).
Koechel et al., "Diuretic activity of Mannich base derivatives of ethacrynic acid and certain ethacrynic acid analogs", Chemical Abstracts 89:53289 (1978).
Cragoe et al, "(1-Oxo-2-halo-5-indanyloxy)alkanoic acids", Chemical Abstracts 82:17084 (1975).
Cragoe et al., "Diuretic and saluretic (1-oxo-2-alkylidene-5-indanyloxy(thio)acetic acids", Chemical Abstracts 73:25182f (1970).
Cragoe and Woltersdorf, "Diuretic and saluretic substituted (1-oxoinden-5-yl-oxy)acetic acids", Chemical Abstracts 73:25181e (1970).
Cragoe et al., "Antiinflammatory 3,4-dihydro2H pyran", Heterocyclic Compounds 71:91305h (1969).
Cragoe et al., "a[(a-Methylenealkanoyl)phenoxy]alkanoic acids", Chemical Abstracts 71:70324y (1969).
Merck & Co., Inc., "2-(Hydrocarbyipolythiomethyl)alkanoyl phenoxyacetic acids", Chemical Abstracts 66:104824a (1967).
Epstein et al., "Ethacrynic Acid Uniquely Disrupts Cellular Tubulin in Trabecular and Other Endothelial Cells", Arvo Abstract (1991).
Hooshmand and Epstein, "Thiol Adducts of Ethacrynic Acid Increase Outflow Facility in Enucleated Calf Eyes", Arvo Abstract (1991).
Schroeder et al., "Topical Ethacrynic Acid Lowers Intraocular Pressure in Rabbits and Monkeys", Arvo Abstract (1991).
Gere, M., "Risk of postcataract IOP spike justified prophylactic drugs", Ocular Surgery News vol. 8, No. 14 (1990).
Koechel and Cafruny, "Thiol Adducts of Ethacrynic Acid: A Correlation of the Rate of Liberation of Ethacrynic Acid w/the Onset & Magnitude of the Diuretic Response", The Journal of Pharmacology and Experimental Therapeutics 192:179-194 (1975).
Cragoe, E. J., "The (Aryloxy)acetic Acid Family of Diuretics", J. Clin. Pharmacol. 9, 577:203-223 (1980).
Liang et al., "Ethacrynic Acid Increases Facility of Outflow in the Human Eye In Vitro", Arvo Abstracts 1849 (1990).
Green and Mayberry, "Drug Effects on the Hydraulic Conductivity of the Isolated Rabbit Ciliary Epithelium", Quarterly J. Exp. Physiol. 70:271-281 (1985).
Neubauer and Severin, "Glaukom", Therapiewocke 25:7467-7470 (1975).
Epstein et al., "The Search for a Sulfhydryl Drug for Glaucoma", Invest. Opthalmol. Vis. Sci. 27 (Suppl. 3) 179 (1986).
Fay Zohreh
Massachusetts Eye and Ear Infirmary
LandOfFree
Method and products for treating the eye does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Method and products for treating the eye, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method and products for treating the eye will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1712018